Textured Breast Implant Recall
At the FDA ’s request, Allergan plc agreed to recall its Biocell textured breast implants and tissue expanders due to an increased risk of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL)—a type of non-Hodgkin lymphoma.
Source: JAMA - Category: General Medicine Source Type: research
More News: Allergy | Breast Augmentation | General Medicine | Lymphoma | Non-Hodgkin's Lymphoma | Plastic Surgery